0000899243-20-035279.txt : 20201228 0000899243-20-035279.hdr.sgml : 20201228 20201228192002 ACCESSION NUMBER: 0000899243-20-035279 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201222 FILED AS OF DATE: 20201228 DATE AS OF CHANGE: 20201228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Epstein Marie CENTRAL INDEX KEY: 0001834469 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37695 FILM NUMBER: 201419711 MAIL ADDRESS: STREET 1: C/O YUMANITY THERAPEUTICS, INC. STREET 2: 40 GUEST STREET, SUITE 4410 CITY: BOSTON STATE: MA ZIP: 02135 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: YUMANITY THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001445283 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 80 GUEST STREET STREET 2: 5TH FLOOR CITY: BOSTON STATE: MA ZIP: 02135 BUSINESS PHONE: 617-225-0096 MAIL ADDRESS: STREET 1: 80 GUEST STREET STREET 2: 5TH FLOOR CITY: BOSTON STATE: MA ZIP: 02135 FORMER COMPANY: FORMER CONFORMED NAME: PROTEOSTASIS THERAPEUTICS, INC. DATE OF NAME CHANGE: 20140813 FORMER COMPANY: FORMER CONFORMED NAME: PROTEOSTASIS THERAPEUTICS INC DATE OF NAME CHANGE: 20080916 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-22 0 0001445283 YUMANITY THERAPEUTICS, INC. YMTX 0001834469 Epstein Marie C/O YUMANITY THERAPEUTICS, INC 40 GUEST STREET, SUITE 4410 BOSTON MA 02135 0 1 0 0 Principal Accounting Officer Stock Option (Right to Buy) 8.16 2020-12-22 4 A 0 38373 A 2028-12-03 Common Stock 38373 38373 D Stock Option (Right to Buy) 8.16 2020-12-22 4 A 0 4216 A 2030-02-17 Common Stock 4216 4216 D On August 22, 2020, the Issuer (formerly known as Proteostasis Therapeutics, Inc.) entered into an Agreement and Plan of Merger and Reorganization, as amended on November 6, 2020, with Pangolin Merger Sub, Inc. ("Merger Sub"), Yumanity, Inc. (formerly known as Yumanity Therapeutics, Inc.) and Yumanity Holdings, LLC ("Holdings"). On December 22, 2020, Merger Sub was merged with and into Yumanity, Inc., with Yumanity, Inc. surviving as a wholly-owned subsidiary of the Issuer (the "Merger"). Immediately prior to the consummation of the Merger, Holdings was merged with and into Yumanity, Inc., with Yumanity, Inc. as the surviving entity. 25% of the shares subject to the option vested on July 31, 2019. The remaining 75% vest in equal monthly installments over the subsequent three years. Received in the Merger in exchange for a stock option to acquire 182,000 shares of Yumanity, Inc. common stock for $1.72 per share. 25% of the shares subject to the option vest on February 18, 2021. The remaining 75% vest in equal monthly installments over the subsequent three years. Received in the Merger in exchange for a stock option to acquire 20,000 shares of Yumanity, Inc. common stock for $1.72 per share. /s/ Marie Epstein 2020-12-28